867 China Medical Systems Breakout / Long IdeaHello Tradingviewians,
CMS has been in a long consolidation to digest lowering growth rates. Additionally it has been under fire by short sellers, alleging CMS of faking revenue numbers.
Should the numbers be genuine, and factors like consistent insider buying suggest it, CMS represents serious val
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.72 HKD
1.76 B HKD
8.10 B HKD
1.18 B
About CHINA MEDICAL SYSTEM HLDGS LTD
Sector
Industry
CEO
Kong Lam
Website
Headquarters
Shenzhen
Founded
1995
FIGI
BBG0015X4QW2
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 867 is 8.14 HKD — it has increased by 1.52% in the past 24 hours. Watch CHINA MEDICAL SYSTEM HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CHINA MEDICAL SYSTEM HLDGS LTD stocks are traded under the ticker 867.
867 stock has fallen by −3.16% compared to the previous week, the month change is a −11.45% fall, over the last year CHINA MEDICAL SYSTEM HLDGS LTD has showed a 16.29% increase.
We've gathered analysts' opinions on CHINA MEDICAL SYSTEM HLDGS LTD future price: according to them, 867 price has a max estimate of 12.46 HKD and a min estimate of 9.32 HKD. Watch 867 chart and read a more detailed CHINA MEDICAL SYSTEM HLDGS LTD stock forecast: see what analysts think of CHINA MEDICAL SYSTEM HLDGS LTD and suggest that you do with its stocks.
867 stock is 12.24% volatile and has beta coefficient of 0.83. Track CHINA MEDICAL SYSTEM HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is CHINA MEDICAL SYSTEM HLDGS LTD there?
Today CHINA MEDICAL SYSTEM HLDGS LTD has the market capitalization of 17.76 B, it has increased by 0.82% over the last week.
Yes, you can track CHINA MEDICAL SYSTEM HLDGS LTD financials in yearly and quarterly reports right on TradingView.
CHINA MEDICAL SYSTEM HLDGS LTD is going to release the next earnings report on Aug 14, 2025. Keep track of upcoming events with our Earnings Calendar.
867 earnings for the last half-year are 0.31 HKD per share, whereas the estimation was 0.36 HKD, resulting in a −14.71% surprise. The estimated earnings for the next half-year are 0.36 HKD per share. See more details about CHINA MEDICAL SYSTEM HLDGS LTD earnings.
CHINA MEDICAL SYSTEM HLDGS LTD revenue for the last half-year amounts to 4.11 B HKD, despite the estimated figure of 4.33 B HKD. In the next half-year revenue is expected to reach 4.22 B HKD.
867 net income for the last half-year is 769.53 M HKD, while the previous report showed 986.56 M HKD of net income which accounts for −22.00% change. Track more CHINA MEDICAL SYSTEM HLDGS LTD financial stats to get the full picture.
CHINA MEDICAL SYSTEM HLDGS LTD dividend yield was 3.85% in 2024, and payout ratio reached 40.22%. The year before the numbers were 3.09% and 39.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 22, 2025, the company has 6.14 K employees. See our rating of the largest employees — is CHINA MEDICAL SYSTEM HLDGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA MEDICAL SYSTEM HLDGS LTD EBITDA is 2.07 B HKD, and current EBITDA margin is 25.58%. See more stats in CHINA MEDICAL SYSTEM HLDGS LTD financial statements.
Like other stocks, 867 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA MEDICAL SYSTEM HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA MEDICAL SYSTEM HLDGS LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA MEDICAL SYSTEM HLDGS LTD stock shows the sell signal. See more of CHINA MEDICAL SYSTEM HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.